184 related articles for article (PubMed ID: 2780109)
1. [Biochemical markers of the tumor origin of ascites].
Romette J; di Costanzo-Dufetel J
Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
3. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
[TBL] [Abstract][Full Text] [Related]
4. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
5. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
6. [Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].
Cabral JE; Leitão MC; Guerra C; Tomé L; Pinto ML; Costa D; Monteiro G
Acta Med Port; 1989; 2(1):17-20. PubMed ID: 2773676
[TBL] [Abstract][Full Text] [Related]
7. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
[TBL] [Abstract][Full Text] [Related]
8. Measurement of fibronectin concentration in benign and malignant ascites.
Adamsen S; Jönsson P; Brodin B; Lindberg B; Jorpes P
Eur J Surg; 1991 May; 157(5):325-8. PubMed ID: 1678645
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing ascitic etiology on a biochemical basis.
Bansal S; Kaur K; Bansal AK
Hepatogastroenterology; 1998; 45(23):1673-7. PubMed ID: 9840127
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
11. Ascitic fluid cholesterol in differential diagnosis of ascites.
Garg R; Sood A; Arora S; Bhatia KL; Chawla AS; Gupta R; Chawla LS
J Assoc Physicians India; 1993 Oct; 41(10):644-6. PubMed ID: 8294324
[TBL] [Abstract][Full Text] [Related]
12. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.
Jüngst D; Gerbes AL; Martin R; Paumgartner G
Hepatology; 1986; 6(2):239-43. PubMed ID: 3957233
[TBL] [Abstract][Full Text] [Related]
13. Role of fibronectin in diagnosis of malignant ascites.
Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
[TBL] [Abstract][Full Text] [Related]
14. [Tumor markers and immunomodulator substances in ascites--their value as screening and diagnosis parameters].
Satz N; Joller-Jemelka HI; Grob PJ; Hofer C; Schmid E; Knoblauch M
Schweiz Med Wochenschr; 1989 May; 119(21):762-5. PubMed ID: 2474198
[TBL] [Abstract][Full Text] [Related]
15. Origin of fat in chylous ascites of patients with liver cirrhosis.
Malagelada JR; Iber FL; Linscheer WG
Gastroenterology; 1974 Nov; 67(5):878-86. PubMed ID: 4426492
[No Abstract] [Full Text] [Related]
16. Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites.
Dwivedi M; Misra SP; Misra V; Kumar R
Am J Gastroenterol; 1990 Sep; 85(9):1123-5. PubMed ID: 2389724
[TBL] [Abstract][Full Text] [Related]
17. Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.
Gerbes AL; Xie YN; Mezger J; Jüngst D
Liver; 1990 Jun; 10(3):152-7. PubMed ID: 2385156
[TBL] [Abstract][Full Text] [Related]
18. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
[TBL] [Abstract][Full Text] [Related]
20. [Chylous ascites in cirrhotic and non-cirrhotic patients].
Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]